NCT07170293 2025-09-12Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid TumorsTianjin Medical University Second HospitalPhase 2 Recruiting15 enrolled
NCT07030478 2025-06-22A Study to Evaluate the Safety and Tolerability of EP0089Ellipses PharmaPhase 1/2 Not yet recruiting190 enrolled